Page 2 - Ranbaxy
Ranbaxy recovers; U.S. fine overhang seen ending
Ranbaxy recovers; U.S. fine overhang seen ending
The Ranbaxy case and how it shows the system in India does work after all
Many global giants might have lost money in their India ventures, but the Delhi HC's order last fortnight asking the Singh brothers to pay up in the Ranbaxy-Daiichi dispute should make everyone feel a
 "The Ranbaxy case and how it shows the system in India does work after all")
Daiichi case: HC tells Singh brothers to disclose stake in group entities
Daiichi can access previous asset declarations by Singh Brothers on affidavit of confidentiality
 "Daiichi case: HC tells Singh brothers to disclose stake in group entities")
Ranbaxy portfolio makes up for 37% of Sun's India sales
Ranbaxy contributes a little lower than Rs 3k cr to the India sales of the merged entity
 "Ranbaxy portfolio makes up for 37% of Sun's India sales")
Ranbaxy seeks USFDA nod for withdrawing 28 drug applications
The older drugs belong to erstwhile Ranbaxy Labs and have not been marketed in the US since 2008
 "Ranbaxy seeks USFDA nod for withdrawing 28 drug applications")
Daiichi case: Former Ranbaxy promoters object to enforcement of Singapore arbitration award in India
Malvinder Singh and Shivinder Singh were accused of concealing information regarding wrongdoing at Ranbaxy when they sold a majority stake in it to the Japanese firm in 2008
 "Daiichi case: Former Ranbaxy promoters object to enforcement of Singapore arbitration award in India")
Pay Rs 2,500 cr to Daiichi for hiding facts, court tells ex-Ranbaxy promoters Malvinder & Shivinder Mohan Singh
The two had sold their entire stake of about 35% in Ranbaxy for $2.4 bn in 2008 to Daiichi Sankyo
 "Pay Rs 2,500 cr to Daiichi for hiding facts, court tells ex-Ranbaxy promoters Malvinder & Shivinder Mohan Singh")
